Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer

Triple-negative breast cancer (TNBC), defined as loss of estrogen, progesterone, and Her2 receptors, is a subtype of highly aggressive breast cancer with worse prognosis and poor survival rate. Macrophage migration inhibitory factor (MIF) is a pleiotropic pro-inflammatory cytokine aberrantly express...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Death Dis
Autors principals: Charan, Manish, Das, Subhadip, Mishra, Sanjay, Chatterjee, Nabanita, Varikuti, Sanjay, Kaul, Kirti, Misri, Swati, Ahirwar, Dinesh K., Satoskar, Abhay R., Ganju, Ramesh K.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498597/
https://ncbi.nlm.nih.gov/pubmed/32943608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-02992-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars